Your browser doesn't support javascript.
loading
The anti-tumor agent, Dp44mT, promotes nuclear translocation of TFEB via inhibition of the AMPK-mTORC1 axis.
Krishan, S; Sahni, S; Richardson, D R.
Affiliation
  • Krishan S; Molecular Pharmacology and Pathology Program, Department of Pathology and Bosch Institute, Medical Foundation Building (K25), University of Sydney, Sydney, New South Wales 2006, Australia.
  • Sahni S; Molecular Pharmacology and Pathology Program, Department of Pathology and Bosch Institute, Medical Foundation Building (K25), University of Sydney, Sydney, New South Wales 2006, Australia; Northern Clinical School, Faculty of Medicine and Health, University of Sydney, NSW, Australia; Kolling Institute of Medical Research, St Leonards, NSW, Australia. Electronic address: sumit.sahni@sydney.edu.au.
  • Richardson DR; Molecular Pharmacology and Pathology Program, Department of Pathology and Bosch Institute, Medical Foundation Building (K25), University of Sydney, Sydney, New South Wales 2006, Australia; Department of Pathology and Biological Responses, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan; Centre for Cancer Cell Biology and Drug Discovery, Griffith Institute for Drug Discovery, Griffith University, Nathan, Brisbane, Queensland 4111, Australia. Electronic address: d.richardson@
Biochim Biophys Acta Mol Basis Dis ; 1866(12): 165970, 2020 12 01.
Article in En | MEDLINE | ID: mdl-32950675

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thiosemicarbazones / Cell Nucleus / Basic Helix-Loop-Helix Leucine Zipper Transcription Factors / AMP-Activated Protein Kinases / Mechanistic Target of Rapamycin Complex 1 / Antineoplastic Agents Limits: Humans Language: En Journal: Biochim Biophys Acta Mol Basis Dis Year: 2020 Document type: Article Affiliation country: Australia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thiosemicarbazones / Cell Nucleus / Basic Helix-Loop-Helix Leucine Zipper Transcription Factors / AMP-Activated Protein Kinases / Mechanistic Target of Rapamycin Complex 1 / Antineoplastic Agents Limits: Humans Language: En Journal: Biochim Biophys Acta Mol Basis Dis Year: 2020 Document type: Article Affiliation country: Australia